The Endocannabinoid System of Animals
This review paper by Dr. Robert Silver gives an overview of the ECS in animals and highlights it as a topic of interest for emerging therapeutics.
This category needs to be renamed to be meaningful than “Miscellaneous” but it will do for now. Basically it’s intended for news, research, legal actions and other information about medical marijuana for the general, nonexpert audience: patients, jouralists, the curious, etc.
Cannabis education needs assessment among Canadian physicians-in-training.
Canadian researchers found that the average training from physicians in training was 25% less than what they desired and that further training was paramount for them to engage in cannabis for therapeutic purposes (2020).
The influence cannabidiol on delayed onset of muscle soreness
CBD appears to have a significant influence on muscle soreness associated with exercise induced muscle damage and delayed onset of muscle soreness when consumed immediately after strenuous exercise.
Value Of Cannabis Based Medicine (podcast)
Dr. Sherry Yafai is an ER doctor who also integrates cannabis-based medicine in her clinical practice at The Releaf Institute. In this interview with Joe Lemon, she explores the reasons why cannabis- informed healthcare providers are needed more and more.
Cannabis For Senior Mental Health
Dr. Phillip Grob, a geriatric psychiatrist, discusses the potential applications of cannabis for dementia and mental health challenges in the senior population.
Opiates & Cannabis: Current Perspectives & Case Studies
Dr. Sherry Yafai of the Releaf Institute discusses the applications of cannabis to reduce or replace the use of opiate drugs. She outlines the opioid epidemic and how cannabis may be used as a tool for harm reduction.
The Antitumor Properties of Cannabis: Preclinical Evidence
Dr. Cristina Sanchez, a biochemist with over 20 years of experience as a cannabinoid researcher, outlines the preclinical evidence of cannabinoids on different types of cancer.
From Cultivar to Chemovar: An Update on Cannabis Varieties
Dr. Arno Hazekamp discusses the intricacies of the Sativa/Indica debate. He describes metabolic characterists of cannabis constituents and the characteristics of hybrids. Originally recorded at the SCC Quarterly Meeting in March of 2018.
Tourette Syndrome: Clinical Presentation, Underlying Pathology and Treatment Options
Dr. Kirsten Muller-Vahl, is a physician specializing in neurology and psychiatry, is the world’s authority on cannabis and Tourette’s syndrome. She presents “Tourette Syndrome: Clinical presentation, underlying pathology and treatment options” at the February SCC Quarterly Meeting on January 4, 2018.
Cancer Biology and Cannabinoid Research: David (Dedi) Meiri, PhD
Dr. David (Dedi) Meiri presents on “Laboratory of Cancer Biology and Cannabinoid Research” at the SCC Quarterly Meeting on September 17, 2017